发明名称 Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
摘要 The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R1, R2, R3, R4, R5, A1, A2, A3, A4, and A5, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.
申请公布号 US2012165519(A1) 申请公布日期 2012.06.28
申请号 US201213413322 申请日期 2012.03.06
申请人 AHMED GULZAR;BRESLIN HENRY JOSEPH;BURKE JASON;CURRY MATTHEW A.;DIEBOLD JAMES L.;DORSEY BRUCE;DUGAN BENJAMIN J.;FENG DAMING;GINGRICH DIANE E.;GUO TAO;LEARN KEITH S.;LISKO JOSEPH G.;LIU RONG-QIANG;MESAROS EUGEN;MILKIEWICZ KAREN;OTT GREGORY R.;THEROFF JAY P.;THIEU THO V.;TRIPATHY RABINDRANATH;UNDERINER THEODORE L.;WELLS GREGORY J.;ZIFICSAK CRAIG A.;CEPHALON, INC. 发明人 AHMED GULZAR;BRESLIN HENRY JOSEPH;BURKE JASON;CURRY MATTHEW A.;DIEBOLD JAMES L.;DORSEY BRUCE;DUGAN BENJAMIN J.;FENG DAMING;GINGRICH DIANE E.;GUO TAO;LEARN KEITH S.;LISKO JOSEPH G.;LIU RONG-QIANG;MESAROS EUGEN;MILKIEWICZ KAREN;OTT GREGORY R.;THEROFF JAY P.;THIEU THO V.;TRIPATHY RABINDRANATH;UNDERINER THEODORE L.;WELLS GREGORY J.;ZIFICSAK CRAIG A.
分类号 C07D403/14;C07D401/14;C07D403/12;C07D405/12;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/14;C07D498/04 主分类号 C07D403/14
代理机构 代理人
主权项
地址